首页> 外文期刊>Cellular Physiology and Biochemistry >Bioactive Peptide Improves Diet-Induced Hepatic Fat Deposition and Hepatocyte Proinflammatory Response in SAMP8 Ageing Mice
【24h】

Bioactive Peptide Improves Diet-Induced Hepatic Fat Deposition and Hepatocyte Proinflammatory Response in SAMP8 Ageing Mice

机译:生物活性肽改善饮食诱导的SAMP8衰老小鼠的肝脂肪沉积和肝细胞促炎反应

获取原文
获取外文期刊封面目录资料

摘要

Background/Aims High-fat diet (HFD)-induced nonalcoholic fatty liver disease (NAFLD) poses therapeutic challenges in elderly subjects. Due to lack of efficient drug therapy, plant-based bioactive peptides have been studied as alternative strategy in NAFLD and for less toxicity in elderly. To mimic fatty liver in aging conditions, researchers highly commended the genetically engineered strains SAMP8 (senescence-accelerated mice prone 8). However, there is a paucity of reports about the anti-steatosis effects of bioactive peptides against fatty liver development under a combined action of high-fat diet exposure and aging process. This study was conducted to evaluate the activity of DIKTNKPVIF peptide synthesized from alcalase-generated potato protein hydrolysate (PH), on reducing HFD-driven and steatosis-associated proinflammatory reaction in ageing model. Methods Five groups of six-month-old SAMP8 mice (n=4, each) were fed either a normal chow (NC group) for 14 weeks upon sacrifice, or induced with a 6-week HFD feeding, then treated without (HCO group) or with an 8-week simultaneous administration of peptide (HPEP group), protein (HPH group) or probucol (HRX group). Liver organs were harvested from each group for histological analysis and immunoblot assay. Results In contrast to NC, extensive fat accumulation was visualized in the liver slides of HCO. Following the trends of orally administered PH, intraperitoneally injected peptide reduces hepatic fat deposition and causes at protein level, a significant decrease in HFD-induced proinflammatory mediators p-p38 MAPK, FGF-2, TNF-α, IL-6 with concomitant reactivation of AMPK. However, p-Foxo1 and PPAR-α levels were slightly changed. Conclusion Oral supplementation of PH and intraperitoneal injection of derived bioactive peptide alleviate proinflammatory reaction associated with hepatosteatosis development in elderly subjects, through activation of AMPK.
机译:背景/目的高脂饮食(HFD)诱发的非酒精性脂肪肝疾病(NAFLD)对老年受试者提出治疗挑战。由于缺乏有效的药物治疗,已经研究了以植物为基础的生物活性肽作为NAFLD的替代策略,并降低了老年人的毒性。为了模仿衰老条件下的脂肪肝,研究人员高度赞扬了基因工程菌株SAMP8(衰老加速小鼠倾向于8)。然而,在高脂饮食和衰老过程的共同作用下,关于生物活性肽对脂肪肝发育的抗脂肪变性作用的报道很少。这项研究旨在评估由alcalase产生的马铃薯蛋白水解产物(PH)合成的DIKTNKPVIF肽在减少衰老模型中由HFD驱动和与脂肪变性相关的促炎反应中的活性。方法5组6个月大的SAMP8小鼠(n = 4,每只)在处死后以正常食物喂养(NC组)14周,或以6周的HFD喂养进行诱导,然后不予治疗(HCO组) )或同时服用8周的多肽(HPEP组),蛋白质(HPH组)或普罗布考(HRX组)。从每组中收集肝器官用于组织学分析和免疫印迹测定。结果与NC相反,在HCO的肝脏切片中可见大量脂肪堆积。遵循口服PH的趋势,腹膜内注射的肽减少了肝脏脂肪沉积并在蛋白质水平上引起,在HFD诱导的促炎介质p-p38 MAPK,FGF-2,TNF-α,IL-6显着降低,同时伴随着HIF的重新活化。 AMPK。但是,p-Foxo1和PPAR-α水平略有变化。结论口服PH补充和腹膜内注射衍生的生物活性肽可通过激活AMPK减轻与老年肝脂肪变性病相关的促炎症反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号